3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
10
Mesothelioma, Malignant
3
Solid Tumors
2
Advanced Solid Tumors
2
Unspecified Childhood Solid Tumor, Protocol Specific
1
Mesothelioma
1
Advanced or Metastatic Solid Tumors
1
Advanced Non-Small Cell Lung Cancer
1
Interventions
pembrolizumab
4
envafolimab
3
Nivolumab
3
Injections
2
trifluridine tipiracil drug combination
1
tebentafusp
1
surufatinib
1
sintilimab
1
linifanib
1
fludarabine
1
cobimetinib
1
TAK-981
1
Ipilimumab
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Combined Modality Therapy
1
Bortezomib
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced or Metastatic Solid Tumors
×
Bortezomib
×
Other solid neoplasm
×
Clear all
NCT02220049
2016-03-25
VELDAY
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1
Completed
18 enrolled